Ophthalmology · Winston Salem, NC
NPI
1023192911
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1340 Creekshire Way
Winston Salem, NC, 27103
Phone (919) 620-4467
Groups this clinician bills Medicare through
Medicare paid, 2024
$253K
3,691 services
Medicare patients, 2024
492
Average age 76
Drug cost, 2024
$1.1M
9,162 prescriptions
Company payments, 2025
$72.05
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frank J Moya was code 99214 (office e&m - established), 661 times for 356 patients. In total Frank J Moya billed 3,691 services in 46 codes, and Medicare paid $253K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 661 | 356 | $80.39 | $53K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 595 | 337 | $11.34 | $6,749 |
| 66984 Cataract Surgery | Office | 588 | 83 | $74.85 | $44K |
| 92083 Vision, Hearing, and Speech Services | Office | 401 | 319 | $39.95 | $16K |
| 92136 Ultrasound - Nonspecific | Office | 360 | 164 | $25.80 | $9,288 |
| 92133 Computerized Ophthalmic Imaging | Office | 243 | 234 | $23.58 | $5,730 |
| 66982 Cataract Surgery | Office | 116 | 17 | $79.77 | $9,253 |
| 99204 Office E&M - New | Office | 110 | 110 | $102.16 | $11K |
| 92020 Ophthalmological E&M | Office | 85 | 76 | $20.18 | $1,715 |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 76 | 67 | $167.21 | $13K |
| 76514 Ultrasound - Nonspecific | Office | 58 | 58 | $7.83 | $454 |
| 66988 Cataract Surgery | Office | 50 | 25 | $201.72 | $10K |
| 65820 Fluid Flow and Drainage of Eye (Any Method) | Office | 46 | 30 | $556.87 | $26K |
| 66821 Cataract Surgery | Office | 39 | 32 | $216.25 | $8,434 |
| 99211 Office E&M - Established | Office | 33 | 31 | $16.64 | $549 |
By year: 2022 $250K for 3,436 services; 2023 $233K for 3,023 services; 2024 $253K for 3,691 services.
Medicare prescription drug claims, 2024
In 2024, the drug Frank J Moya prescribed most often to Medicare patients was Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat), with 1,509 prescriptions and refills. In total Frank J Moya wrote 9,162 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 1,509 | 3,578 | 460 | $23K |
| Latanoprost Generic | 1,465 | 3,228 | 460 | $18K |
| Brimonidine Tartrate Generic | 1,429 | 2,775 | 406 | $20K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 703 | 1,091 | 183 | $375K |
| Ketorolac Tromethamine Generic | 702 | 752 | 414 | $14K |
| Dorzolamide Hcl Generic | 538 | 1,153 | 160 | $12K |
| Moxifloxacin Moxifloxacin Hcl | 470 | 471 | 394 | $10K |
| Prednisolone Acetate Generic | 451 | 561 | 333 | $13K |
| Rhopressa Netarsudil Mesylate | 330 | 542 | 95 | $168K |
| Lumigan Bimatoprost | 226 | 436 | 68 | $108K |
| Timolol Maleate Generic | 218 | 517 | 79 | $5,098 |
| Vyzulta Latanoprostene Bunod | 183 | 280 | 46 | $76K |
| Methazolamide Generic | 129 | 210 | 34 | $47K |
| Travoprost Generic | 98 | 207 | 31 | $16K |
| Simbrinza Brinzolamide/Brimonidine Tart | 75 | 126 | 18 | $23K |
Brand drugs: 2,740 claims; generic drugs: 6,422 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frank J Moya $72.05 ($72.05 in general payments such as food, travel and fees) from 2 companies. The largest payer was Johnson & Johnson Surgical Vision, Inc. with $49.48.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.